메뉴 건너뛰기




Volumn 63, Issue 2, 2006, Pages 173-175

Nano- and micro-particulate formulations of poorly water-soluble drugs by using a novel optimized technique

Author keywords

Microparticles; Mixer technique; Nanoparticles; Poorly water soluble drugs; Precipitation

Indexed keywords

BETAMETHASONE VALERATE; CARBAMAZEPINE; LIPID; NANOPARTICLE; OXCARBAZEPINE; POLYMER; PROGESTERONE; SURFACTANT; WATER;

EID: 33646836468     PISSN: 09396411     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejpb.2006.02.004     Document Type: Article
Times cited : (85)

References (12)
  • 1
    • 0343527392 scopus 로고    scopus 로고
    • Modern bioavailability, bioequivalence and biopharmaceutics classification system. New scientific approaches to international regulatory standards
    • Amidon G.L., and Löbenberg R. Modern bioavailability, bioequivalence and biopharmaceutics classification system. New scientific approaches to international regulatory standards. Eur. J. Pharm. Biopharm. 50 (2000) 3-12
    • (2000) Eur. J. Pharm. Biopharm. , vol.50 , pp. 3-12
    • Amidon, G.L.1    Löbenberg, R.2
  • 2
    • 0037223728 scopus 로고    scopus 로고
    • Micronization of anti-inflammatory drugs for pulmonary delivery by a controlled crystallization process
    • Müller B.W., Rasenack N., and Steckel H. Micronization of anti-inflammatory drugs for pulmonary delivery by a controlled crystallization process. J. Pharm. Sci. 92 (2003) 35-44
    • (2003) J. Pharm. Sci. , vol.92 , pp. 35-44
    • Müller, B.W.1    Rasenack, N.2    Steckel, H.3
  • 3
    • 0037467170 scopus 로고    scopus 로고
    • Microcrystals for dissolution rate enhancement of poorly water-soluble drugs
    • Müller B.W., Rasenack N., and Hartenhauer H. Microcrystals for dissolution rate enhancement of poorly water-soluble drugs. Int. J. Pharm. 254 (2003) 137-145
    • (2003) Int. J. Pharm. , vol.254 , pp. 137-145
    • Müller, B.W.1    Rasenack, N.2    Hartenhauer, H.3
  • 7
    • 33646831456 scopus 로고    scopus 로고
    • B. Kühn, Verfahren und Vorrichtung zur In-Situ-Formulierung einer Arzneistofflösung zur parenteralen Applikation. German Patent No. WO 99/32175 A1 (1999).
  • 8
    • 25144515860 scopus 로고    scopus 로고
    • A new formulation concept with drugs with poor water solubility for parenteral application
    • Jürgens K., and Müller B.W. A new formulation concept with drugs with poor water solubility for parenteral application. Pharmazie 60 (2005) 665-670
    • (2005) Pharmazie , vol.60 , pp. 665-670
    • Jürgens, K.1    Müller, B.W.2
  • 9
    • 0028200490 scopus 로고
    • Hydrosols - alternatives for the parenteral application of poorly water soluble drugs
    • Gassmann P., List M., Schweitzer A., and Sucker H. Hydrosols - alternatives for the parenteral application of poorly water soluble drugs. Eur. J. Pharm. Biopharm. 40 (1994) 64-72
    • (1994) Eur. J. Pharm. Biopharm. , vol.40 , pp. 64-72
    • Gassmann, P.1    List, M.2    Schweitzer, A.3    Sucker, H.4
  • 10
    • 0035803697 scopus 로고    scopus 로고
    • Organic nanoparticles in the aqueous phase - theory, experiment, and use
    • Horn D., and Rieger J. Organic nanoparticles in the aqueous phase - theory, experiment, and use. Angew. Chem. Int. Ed. 40 (2001) 4330-4361
    • (2001) Angew. Chem. Int. Ed. , vol.40 , pp. 4330-4361
    • Horn, D.1    Rieger, J.2
  • 12
    • 0029867284 scopus 로고    scopus 로고
    • Albumine nanospheres as carriers for passive drug targeting: an optimized manufacturing technique
    • Müller B.J., Leuenberger H., and Kissel T. Albumine nanospheres as carriers for passive drug targeting: an optimized manufacturing technique. Pharm. Res. 13 (1996) 32-37
    • (1996) Pharm. Res. , vol.13 , pp. 32-37
    • Müller, B.J.1    Leuenberger, H.2    Kissel, T.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.